SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050872
Filing Date
2020-11-05
Accepted
2020-11-05 07:31:47
Documents
77
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kymr-10q_20200930.htm 10-Q 3299448
2 EX-10.1 kymr-ex101_540.htm EX-10.1 42810
3 EX-10.2 kymr-ex102_541.htm EX-10.2 102052
4 EX-10.3 kymr-ex103_542.htm EX-10.3 26689
5 EX-31.1 kymr-ex311_9.htm EX-31.1 18300
6 EX-31.2 kymr-ex312_8.htm EX-31.2 18253
7 EX-32.1 kymr-ex321_7.htm EX-32.1 9080
8 EX-32.2 kymr-ex322_6.htm EX-32.2 9346
  Complete submission text file 0001564590-20-050872.txt   9955404

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT kymr-20200930.xml EX-101.INS 1930723
10 XBRL TAXONOMY EXTENSION SCHEMA kymr-20200930.xsd EX-101.SCH 64057
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kymr-20200930_cal.xml EX-101.CAL 56043
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kymr-20200930_def.xml EX-101.DEF 266101
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kymr-20200930_lab.xml EX-101.LAB 517429
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kymr-20200930_pre.xml EX-101.PRE 396843
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39460 | Film No.: 201288697
SIC: 2836 Biological Products, (No Diagnostic Substances)